<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 10 Oct 2026 11:19:05 -0400--><rss version="2.0">
    <channel>
        <title>bioAffinity Technologies, Inc. (BIAF) Press Releases</title>
        <link>https://ir.bioaffinitytech.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://s3.amazonaws.com/equisolve-dev4/bioaffinitytech/files/theme/images/logo-sm.png</url>
                <title>bioAffinity Technologies, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/205/bioaffinity-technologies-inc-announces-closing-of-4-million-registered-direct-financing-of-common-stock-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules</link>
                <pubDate>Fri, 09 Oct 26 11:37:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/205/bioaffinity-technologies-inc-announces-closing-of-4-million-registered-direct-financing-of-common-stock-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/204/bioaffinity-technologies-inc-announces-approximately-4-million-registered-direct-financing-of-common-stock-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules</link>
                <pubDate>Thu, 08 Oct 26 12:07:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/204/bioaffinity-technologies-inc-announces-approximately-4-million-registered-direct-financing-of-common-stock-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/203/bioaffinity-technologies-announces-notification-of-japanese-patent-allowance-covering-noninvasive-cypath-lung-and-ai-built-algorithm</link>
                <pubDate>Thu, 08 Oct 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/203/bioaffinity-technologies-announces-notification-of-japanese-patent-allowance-covering-noninvasive-cypath-lung-and-ai-built-algorithm</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/202/bioaffinity-technologies-reports-over-100-growth-in-cypath-lung-sales-through-third-quarter-2026</link>
                <pubDate>Tue, 06 Oct 26 09:19:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/202/bioaffinity-technologies-reports-over-100-growth-in-cypath-lung-sales-through-third-quarter-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/201/bioaffinity-technologies-promotes-veteran-awareness-and-access-to-its-noninvasive-cypath-lung-cancer-test-through-distribution-partnership-with-veteran-owned-avmedical</link>
                <pubDate>Wed, 30 Sep 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/201/bioaffinity-technologies-promotes-veteran-awareness-and-access-to-its-noninvasive-cypath-lung-cancer-test-through-distribution-partnership-with-veteran-owned-avmedical</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/200/bioaffinity-technologies-to-present-positive-clinical-and-veteran-focused-data-on-cypath-lung-at-navref-2026-annual-conference</link>
                <pubDate>Tue, 22 Sep 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/200/bioaffinity-technologies-to-present-positive-clinical-and-veteran-focused-data-on-cypath-lung-at-navref-2026-annual-conference</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/199/bioaffinity-technologies-announces-grant-of-hong-kong-patent-for-companys-cypath-lung-noninvasive-lung-cancer-diagnostic</link>
                <pubDate>Thu, 17 Sep 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/199/bioaffinity-technologies-announces-grant-of-hong-kong-patent-for-companys-cypath-lung-noninvasive-lung-cancer-diagnostic</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/198/bioaffinity-technologies-regains-compliance-with-nasdaq-listing-requirements</link>
                <pubDate>Wed, 09 Sep 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/198/bioaffinity-technologies-regains-compliance-with-nasdaq-listing-requirements</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/197/bioaffinity-technologies-to-participate-in-the-h-c-wainwright-28th-annual-global-investment-conference</link>
                <pubDate>Thu, 03 Sep 26 16:30:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/197/bioaffinity-technologies-to-participate-in-the-h-c-wainwright-28th-annual-global-investment-conference</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/196/bioaffinity-technologies-advances-cypath-lung-for-surveillance-of-lung-cancer-survivors</link>
                <pubDate>Tue, 01 Sep 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/196/bioaffinity-technologies-advances-cypath-lung-for-surveillance-of-lung-cancer-survivors</guid>
                                                                            </item>
            </channel>
</rss>